Janssen Korea held a press conference to celebrate the launch of Asia's first approved multidrug-resistant tuberculosis (MDR-TB) treatment 'Sirturo'

Published: 2014-04-23 11:35:58

Updated: 2014-04-23 11:35:58

On Apr 21, Janssen Korea held a press conference to celebrate the launch of Asia's first approved multidrug-resistant tuberculosis (MDR-TB) treatment 'Sirturo' (ingredient: Bedaquiline fumarate).

The press conference was composed of twn sessions including last March 21 tyureo ® sikyak wife standing approval from the clinical information sharing of 'Sirturo' which was approved from Ministry of ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.